首页> 美国卫生研究院文献>The EMBO Journal >Structural basis for translational inhibition by the tumour suppressor Pdcd4
【2h】

Structural basis for translational inhibition by the tumour suppressor Pdcd4

机译:肿瘤抑制因子Pdcd4抑制翻译的结构基础

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Pdcd4 is a tumour suppressor protein. It inhibits translation through interaction with translation initiator eIF4A, resulting in the suppression of neoplastic transformation and tumour invasion. Here, we present the crystal structures of an N-terminal-truncated Pdcd4 in free form and in complex with eIF4A. Upon binding to eIF4A, Pdcd4 undergoes a marked conformational change to form a heterotrimeric complex with eIF4A, with one Pdcd4 binding to two eIF4A molecules in two different modes. The binding of Pdcd4 to eIF4A is required to inhibit the enzymatic activity of eIF4A, translation initiation, and AP-1-dependent transcription. Both MA3 domains are required to efficiently compete with the C-terminal domain of eIF4G (eIF4Gc) for binding to eIF4A whereas a single MA3 is sufficient to inhibit translation. Our structural and mutational analyses reveal that Pdcd4 inhibits translation initiation by trapping eIF4A in an inactive conformation, and blocking its incorporation into the eIF4F complex.
机译:Pdcd4是一种肿瘤抑制蛋白。它通过与翻译引发剂eIF4A相互作用来抑制翻译,从而抑制了肿瘤转化和肿瘤侵袭。在这里,我们以自由形式和与eIF4A的复合物形式呈现N端截短的Pdcd4的晶体结构。与eIF4A结合后,Pdcd4发生明显的构象变化,与eIF4A形成异源三聚体复合物,其中一个Pdcd4以两种不同的方式与两个eIF4A分子结合。需要Pdcd4与eIF4A的结合才能抑制eIF4A的酶促活性,翻译起始和AP-1依赖性转录。需要两个MA3域与eIF4G(eIF4Gc)的C末端域有效竞争结合eIF4A,而单个MA3足以抑制翻译。我们的结构和突变分析表明,Pdcd4通过将eIF4A捕获在非活性构象中并阻止其掺入eIF4F复合物中来抑制翻译起始。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号